Navigation Links
AFFiRiS Begins Development of a Parkinson's Vaccine
Date:12/11/2008

et for treating the cause - not just the symptoms - of Parkinson's. However, it is important to bear in mind that alpha-syn is a human protein belonging to a family of proteins with very similar structures like e.g. beta-syn, an essential neuroprotective factor. Therefore, treatment to reduce alpha-syn must not lead to the reduction of related proteins, such as beta-syn. Our AFFITOME technology enables us to develop vaccines that induce antibody specifically targeting alpha-syn only."

Frank Mattner, Chief Scientific Officer at AFFiRiS, adds: "The great potential offered by our AFFITOME technology has been confirmed by external experts, who appraised our development of a Parkinson's vaccine for the Austrian Research Promotion Agency (FFG). Their assessment prompted the FFG to provide considerable financial support for this project."

The AFFITOME technology from AFFiRiS provides a means of targeting very specific structures of human rogue proteins with patented product candidates. AFFiRiS has already succeeded in developing two vaccines and a hemodialysis program for the treatment of Alzheimer's. These therapies only target specific structures found on harmful fragments of beta-amyloid, which is said to be responsible for Alzheimer's. Both Alzheimer's vaccines are currently being trialled on Alzheimer patients. In October, a licence option agreement worth up to EUR 430 million was concluded with GlaxoSmithKline Biologicals for their further clinical development market launch and sales.

About AFFiRiS GmbH (as at December 2008):

AFFiRiS GmbH develops peptide-based vaccines for the treatment of Alzheimer's disease, atherosclerosis and other serious diseases. The company has established its AFFITOME platform technology. It employs 35 highly qualified members of staff on 1,800sqm of rented laboratory facilities at the Campus Vienna Biocenter (http://www
'/>"/>

SOURCE AFFiRiS GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AFFiRiS: Milestone Reached in Clinical Trial of Alzheimers Vaccine
2. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
3. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
4. Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics
5. Patient Recruitment Begins in India for Phase 3 Diabetes Trial
6. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
7. Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins
8. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
9. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
10. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
11. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25, 2014   Heska Corporation (NASDAQ: ... a provider of advanced veterinary diagnostic and other specialty ... Executive Chair, will attend The Benchmark Company, LLC,s Micro Cap ... will be held at The Palmer House Hilton, 17 E. ... a.m. to 2:30 p.m. Please email hska@haydenir.com or ...
(Date:11/26/2014)... BOCA RATON, Fla. , Nov. 25, 2014 ... has entered into a multi-product ANDA agreement with ... Maryland ) under which Breckenridge and Pii ...  Under the terms of the agreement, Pii will ... will market and distribute the products under its ...
(Date:11/26/2014)... and HERZLIYA PITUACH, Israel, Nov. 25, 2014 ... or "the Company"), a clinical stage biopharmaceutical company ... targeted therapeutics for the treatment of inflammatory diseases ... previously announced underwritten public offering of 3,450,000 units, ... the Company,s common stock, par value $0.0001 per ...
Breaking Medicine Technology:Heska to Attend Benchmark Micro Cap Discovery Conference 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5
... ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) ... 31, 2011. "We are pleased to have completed ... the FDA this year to reach agreement on the protocol ... treatment of sickle cell crisis," said Brian M. Culley, Chief ...
... CYPRESS, Calif., May 9, 2011 Medison and Samsung ... Medison. The combined company, a joint partnership between Korea,s ... world,s largest and most technologically-advanced electronics and consumer goods ... into a global leader in medical device industry. ...
Cached Medicine Technology:ADVENTRX Reports First Quarter 2011 Financial Results 2ADVENTRX Reports First Quarter 2011 Financial Results 3ADVENTRX Reports First Quarter 2011 Financial Results 4ADVENTRX Reports First Quarter 2011 Financial Results 5Samsung Medison Pledges to Become a World-Class Medical Device Company 2
(Date:11/27/2014)... Petersburg, Fl (PRWEB) November 28, 2014 Let ... , Beautiful Christmas boxes with bows on top, filled with ... All prices are deeply discounted today while quantities last - ... . , All products are also available on Amazon at ... found on each Sublime shop product page for ease. , ...
(Date:11/27/2014)... England (PRWEB) November 27, 2014 Cambrionix Ltd ... Deloitte Technology Fast 50, a ranking of the 50 fastest-growing ... percentage revenue growth over the last five years. Cambrionix ... Cambrionix Ltd ranked first in the region of Cambridgeshire and ... O’Hara, Managing Director Says:, “This award is recognition of the ...
(Date:11/27/2014)... "As a nurse I see patients every day ... said an inventor from Whiting, N.J. "I put my ... prevent leakage and keep them dry and comfortable." , ... prevents stains on pants, skirts and bottoms, which saves ... the individual has time to get to the bathroom. ...
(Date:11/27/2014)... Thompson HealthDay Reporter WEDNESDAY, ... appears to be safe and produces an immune system response ... early clinical trial results reported by the U.S. National Institutes ... trial for the vaccine paves the way for field-testing it ... Leone as early as January, said Dr. Anthony Fauci, director ...
(Date:11/27/2014)... Indian Trail, NC (PRWEB) November 27, 2014 ... for over 12 years in the Charlotte area ... and fraud examination services to businesses of varying ... with local business owners to meet all of ... received QuickBooks certification through the QuickBooks ProAdvisor Program. ...
Breaking Medicine News(10 mins):Health News:Big Christmas Sales Begin Today at Sublime Beauty® for all Christmas Gift Selections and Skincare Sets 2Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 2Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 3Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 4Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3Health News:Jeffrey Carlini becomes Intuit Proadvisor and receives QuickBooks certification 2
... BERKELEY, CA An $18 million, three-year grant to ... cancer was awarded today to a multi-institutional "Dream Team" ... Gray, a renowned cancer researcher with the U.S. Department ... was awarded by Stand Up To Cancer, an Entertainment ...
... Virtual Event for Research Scientists, Engineers and Professionals Slated for ... Abstracts(at)BioConferenceLive.com , ... Boston, MA (PRWEB) ... media company that produces online events for the healthcare, education ...
... of Insomnia and Potential Solutions NEW YORK, May 27 ... Center for Medicine in the Public Interest (CMPI), has ... and treatment of insomnia translates to billions of dollars ... CMPI also estimates insomnia is responsible for at ...
... suggests what to include in a Pet Evacuation KitSAN ANTONIO, ... 1 and is expected to bring 12 named storms, with ... pets to evacuate or take shelter against these devastating storms ... www.purinacare.com ) suggests preparing a Pet Evacuation ...
... Effectiveness of Managing Data Systems Delivery [While Providing ... SunGard Availability Services has partnered with Phoenix ... outsourcing, consulting and revenue cycle management solutions, to ... records (EMR) and other technologies essential to quality ...
... ban on direct-to-consumer drug advertising and has exposed Canadians ... those for drugs with life-threatening risks, according to a ... and James M. Wright from UBC,s Centre for Health ... drugs from 1995 to 2006 and saw spending rise ...
Cached Medicine News:Health News:Berkeley Lab scientist co-leads breast cancer 'dream team' 2Health News:Berkeley Lab scientist co-leads breast cancer 'dream team' 3Health News:PlatformQ and LabRoots Announce BioConference Live, Online Conference for the Life Science Research and Laboratory Sciences Community 2Health News:PlatformQ and LabRoots Announce BioConference Live, Online Conference for the Life Science Research and Laboratory Sciences Community 3Health News:Ignoring Insomnia Costs America $42 Billion a Year 2Health News:Ignoring Insomnia Costs America $42 Billion a Year 3Health News:Keep Your Pets Safe in a Hurricane 2Health News:SunGard Availability Services and Phoenix Health Systems Join Forces to Deliver Complete Software Application and Infrastructure Management to Community Hospitals 2Health News:SunGard Availability Services and Phoenix Health Systems Join Forces to Deliver Complete Software Application and Infrastructure Management to Community Hospitals 3Health News:SunGard Availability Services and Phoenix Health Systems Join Forces to Deliver Complete Software Application and Infrastructure Management to Community Hospitals 4Health News:Legal loophole exposes Canadians to drug advertising banned in US: UBC research 2